CPT-11 based regimens
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metastatic Colorectal Cancer
Conditions
Metastatic Colorectal Cancer
Trial Timeline
Oct 15, 2009 → Jul 1, 2016
NCT ID
NCT01039506About CPT-11 based regimens
CPT-11 based regimens is a pre-clinical stage product being developed by Daiichi Sankyo for Metastatic Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01039506. Target conditions include Metastatic Colorectal Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Metastatic Colorectal Cancer were approved
Approved (20) Terminated (8) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01039506 | Pre-clinical | Completed |
Competing Products
20 competing products in Metastatic Colorectal Cancer